​

Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?

OverviewForecastFinancialsChartTranscripts

Capricor Therapeutics Ownership Summary

Capricor Therapeutics is owned by 21.16% institutional investors, 9.47% insiders, and 69.37% retail investors. Suvretta capital management is the largest institutional shareholder, holding 8.22% of CAPR shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.70% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCapricor Therapeutics21.16%9.47%69.37%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Suvretta capital management3.82M8.22%$116.09M
Blackrock funding, inc. /de3.42M7.36%$104.02M
Tang capital management3.40M7.32%$103.36M
Vanguard group2.56M5.60%$73.94M
Blackrock1.63M5.19%$7.77M
State street2.18M4.69%$66.33M
Ra capital management1.51M3.24%$45.84M
Geode capital management1.12M2.41%$34.00M
Goldman sachs group911.98K1.96%$27.72M
Point72 asset management821.18K1.77%$24.96M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management3.40M5.25%$103.36M
Dg capital management392.10K3.65%$11.92M
Suvretta capital management3.82M2.96%$116.09M
Boxer capital management590.00K2.35%$17.94M
Ikarian capital528.01K1.30%$16.05M
Moody aldrich partners226.03K1.24%$6.87M
Palo alto investors lp229.76K1.07%$6.98M
Ra capital management1.51M0.49%$45.84M
J. goldman & co lp541.52K0.48%$16.46M
Diadema partners lp78.85K0.41%$2.40M

Top Buyers

HolderShares% AssetsChange
Suvretta capital management3.82M2.96%2.03M
Tang capital management3.40M5.25%1.70M
State street2.18M0.00%1.35M
Blackrock1.63M0.00%1.25M
Blackrock funding, inc. /de3.42M0.00%570.84K

Top Sellers

HolderShares% AssetsChange
Point72 asset management821.18K0.03%-1.02M
Darwin global management---800.00K
Altium capital management lp---714.00K
Soleus capital management---646.39K
Octagon capital advisors lp---450.00K

New Positions

HolderShares% AssetsChangeValue
Mercer global advisors inc /adv403.00K0.02%403.00K$12.25M
Vanguard fiduciary trust320.10K0.00%320.10K$9.73M
Trexquant investment lp222.41K0.05%222.41K$6.76M
Integral health asset management200.00K0.29%200.00K$6.08M
Pfm health sciences, lp123.83K0.34%123.83K$3.76M

Sold Out

HolderChange
True wealth design-5.00
Bare financial services-17.00
Northwestern mutual wealth management-19.00
C m bidwell & associates-43.00
Federated hermes-68.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202698-34.67%10,338,441-62.30%210.59%72-19.10%13-70.45%
Dec 31, 202573-47.86%11,993,578-17.25%262.61%45-30.77%24-33.33%
Sep 30, 2025136-14,466,2445.28%313.50%62-6.06%36-7.69%
Jun 30, 2025132-7.04%13,682,657-27.15%291.77%63-24.10%4037.93%
Mar 31, 202510-92.48%930,147-94.63%20.08%7-92.39%2-86.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.14M3.70%-5.73K
Vanguard Morn Total Stk Mkt Idx Investor1.66M2.86%166.20K
Vanguard Total Stock Mkt Idx Inv1.66M2.86%166.20K
iShares Russell 2000 ETF1.41M2.43%15.18K
Vanguard US Total Market Shares ETF872.18K1.91%-
SPDR® S&P Biotech ETF584.18K1.28%1.30K
Fidelity Select Biotechnology689.45K1.19%355.25K
Vanguard Institutional Extnd Mkt Idx Tr591.35K1.02%70.17K
iShares Russell 2000 Growth ETF489.43K0.85%-
Fidelity Small Cap Index435.48K0.75%4.49K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 25, 2026Krasney Karen EVP, GENERAL COUNSELSell$732.16K
Jun 25, 2026Bergmann Anthony CHIEF FINANCIAL OFFICERSell$732.16K
Jun 24, 2026Krasney Karen EVP, GENERAL COUNSELSell$12.00K
Jun 24, 2026Bergmann Anthony CHIEF FINANCIAL OFFICERSell$12.00K
May 01, 2026Krasney Karen EVP, GENERAL COUNSELSell$792.55K

Insider Transactions Trends

DateBuySell
2026 Q2-6
2026 Q1-3
2025 Q4--
2025 Q1--
2024 Q4--

CAPR Ownership FAQ

Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 21.16%, followed by 9.47% insiders and 69.37% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 35.43%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Suvretta capital management (3.82M shares, 8.22%), Blackrock funding, inc. /de (3.42M shares, 7.36%), and Tang capital management (3.4M shares, 7.32%). Together, they hold 22.89% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Tang capital management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.25% of its assets in 3.4M Capricor Therapeutics shares, valued at 103.36M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Capricor Therapeutics shares, with 3.70% of its total shares outstanding invested in 2.14M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools